Quadrant Capital Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $332K | Buy |
1,244
+19
| +2% | +$5.14K | 0.01% | 1087 |
|
|
2025
Q4 | $307K | Sell |
1,225
-6
| -0.5% | -$1.59K | 0.01% | 1146 |
|
|
2025
Q3 | $353K | Buy |
1,231
+15
| +1% | +$4.02K | 0.01% | 1052 |
|
|
2025
Q2 | $319K | Sell |
1,216
-49
| -4% | -$11.9K | 0.01% | 1105 |
|
|
2025
Q1 | $294K | Buy |
1,265
+800
| +172% | +$194K | 0.01% | 1102 |
|
|
2024
Q4 | $107K | Buy |
465
+19
| +4% | +$4.36K | 0.01% | 1016 |
|
|
2024
Q3 | $99.7K | Sell |
446
-16
| -3% | -$3.52K | 0.01% | 1075 |
|
|
2024
Q2 | $94K | Buy |
462
+58
| +14% | +$11.8K | 0.01% | 1055 |
|
|
2024
Q1 | $88.3K | Sell |
404
-31
| -7% | -$6.83K | 0.01% | 1076 |
|
|
2023
Q4 | $98.9K | Buy |
435
+64
| +17% | +$13.4K | 0.01% | 1002 |
|
|
2023
Q3 | $74.6K | Sell |
371
-48
| -11% | -$10.1K | 0.01% | 1046 |
|
|
2023
Q2 | $86.9K | Sell |
419
-237
| -36% | -$46K | 0.01% | 952 |
|
|
2023
Q1 | $129K | Sell |
656
-244
| -27% | -$50.2K | 0.01% | 697 |
|
|
2022
Q4 | $182K | Buy |
900
+446
| +98% | +$87.2K | 0.02% | 512 |
|
|
2022
Q3 | $80K | Sell |
454
-1
| -0.2% | -$205 | 0.01% | 812 |
|
|
2022
Q2 | $92K | Buy |
455
+106
| +30% | +$22.6K | 0.01% | 657 |
|
|
2022
Q1 | $80K | Sell |
349
-46
| -12% | -$10.8K | 0.01% | 758 |
|
|
2021
Q4 | $107K | Sell |
395
-46
| -10% | -$11.4K | 0.01% | 641 |
|
|
2021
Q3 | $107K | Buy |
441
+11
| +3% | +$2.77K | 0.01% | 599 |
|
|
2021
Q2 | $102K | Buy |
430
+101
| +31% | +$23K | 0.01% | 603 |
|
|
2021
Q1 | $72K | Buy |
329
+18
| +6% | +$3.61K | 0.01% | 690 |
|
|
2020
Q4 | $54K | Sell |
311
-28
| -8% | -$4.84K | 0.01% | 722 |
|
|
2020
Q3 | $55K | Buy |
339
+4
| +1% | +$634 | 0.01% | 629 |
|
|
2020
Q2 | $48K | Sell |
335
-1,077
| -76% | -$149K | 0.01% | 734 |
|
|
2020
Q1 | $155K | Buy |
1,412
+87
| +7% | +$12.5K | 0.03% | 441 |
|
|
2019
Q4 | $184K | Buy |
1,325
+154
| +13% | +$22.2K | 0.02% | 694 |
|
|
2019
Q3 | $163K | Buy |
1,171
+450
| +62% | +$65.7K | 0.03% | 675 |
|
|
2019
Q2 | $101K | Buy |
721
+58
| +9% | +$8.09K | 0.02% | 856 |
|
|
2019
Q1 | $81K | Buy |
663
+464
| +233% | +$57.2K | 0.01% | 926 |
|
|
2018
Q4 | $15K | Buy |
199
+60
| +43% | +$8.04K | ﹤0.01% | 1274 |
|
|
2018
Q3 | $18K | Sell |
139
-1
| -0.7% | -$152 | 0.01% | 1037 |
|
|
2018
Q2 | $18K | Sell |
140
-3
| -2% | -$453 | 0.01% | 1012 |
|
|
2018
Q1 | $13K | Buy |
143
+11
| +8% | +$1.62K | ﹤0.01% | 1145 |
|
|
2017
Q4 | $13K | Buy |
132
+21
| +19% | +$2.77K | 0.01% | 1077 |
|
|
2017
Q3 | $12K | Buy |
111
+48
| +76% | +$6.4K | 0.01% | 1105 |
|
|
2017
Q2 | $6K | Hold |
63
| – | – | ﹤0.01% | 1287 |
|
|
2017
Q1 | $6K | Sell |
63
-102
| -62% | -$12.1K | ﹤0.01% | 1274 |
|
|
2016
Q4 | $16K | Hold |
165
| – | – | 0.01% | 844 |
|
|
2016
Q3 | $17K | Hold |
165
| – | – | 0.01% | 820 |
|
|
2016
Q2 | $16K | Buy |
165
+9
| +6% | +$969 | 0.01% | 798 |
|
|
2016
Q1 | $13K | Buy |
156
+9
| +6% | +$863 | 0.01% | 837 |
|
|
2015
Q4 | $13K | Buy |
147
+17
| +13% | +$1.75K | 0.01% | 680 |
|
|
2015
Q3 | $10K | Buy |
130
+11
| +9% | +$1.14K | 0.01% | 686 |
|
|
2015
Q2 | $12K | Buy |
+119
| New | +$12.4K | 0.01% | 679 |
|
Other funds holding LH
VCM
VPM
Quadrant Capital Group's LH Position: Q1 2026 in Review
Quadrant Capital Group increased its Labcorp (LH) stake by 1.6% in Q1 2026, buying an estimated $5.14K and bringing the position to 1,244 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #1087.
Quadrant Capital Group first reported a position in LH in Q2 2015 and has held it in 44 quarters since. The position peaked at $353K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Quadrant Capital Group held 1,244 shares of Labcorp worth $332K as of Q1 2026.
- Quadrant Capital Group bought 19 Labcorp shares in Q1 2026, an estimated $5.14K.
- Labcorp made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1087 holding.
- Quadrant Capital Group first reported a position in Labcorp in Q2 2015 and has held it in 44 quarters since.
- Quadrant Capital Group's Labcorp position peaked at $353K in Q3 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.